Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.874,77
-0,31%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaccinex Inc (VCNX) Vaccinex Inc (VCNX) Notizie

VCNX

Vaccinex (VCNX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VCNX
DataOraFonteTitoloSimboloCompagnia
16/05/202400:00GlobeNewswire Inc.Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
15/05/202423:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
14/05/202422:36Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
14/05/202422:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
13/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
10/05/202418:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCNXVaccinex Inc
09/05/202423:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
09/05/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
08/05/202418:29Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
02/04/202414:30GlobeNewswire Inc.Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
27/03/202413:30GlobeNewswire Inc.Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VCNXVaccinex Inc
21/02/202414:00GlobeNewswire Inc.Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyNASDAQ:VCNXVaccinex Inc
15/02/202414:00GlobeNewswire Inc.Vaccinex, Inc. Announces Reverse Stock SplitNASDAQ:VCNXVaccinex Inc
13/02/202422:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
09/02/202422:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VCNXVaccinex Inc
08/02/202414:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VCNXVaccinex Inc
07/02/202414:00GlobeNewswire Inc.Vaccinex Announces Pricing of $3.7 Million PIPE FinancingNASDAQ:VCNXVaccinex Inc
10/01/202423:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VCNXVaccinex Inc
08/01/202422:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VCNXVaccinex Inc
28/12/202322:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VCNXVaccinex Inc
04/12/202314:00GlobeNewswire Inc.Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing RuleNASDAQ:VCNXVaccinex Inc
13/11/202314:00GlobeNewswire Inc.Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
31/10/202314:00GlobeNewswire Inc.Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingNASDAQ:VCNXVaccinex Inc
26/10/202315:30GlobeNewswire Inc.Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative DiseasesNASDAQ:VCNXVaccinex Inc
02/10/202315:16Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:VCNXVaccinex Inc
29/09/202302:41Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:VCNXVaccinex Inc
26/09/202314:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
14/09/202323:26Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VCNXVaccinex Inc
25/05/202322:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VCNXVaccinex Inc
19/05/202323:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCNXVaccinex Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VCNX

La tua Cronologia

BIT
P1TCI0
BNP Paribas Issuance
BIT
UC6FWG
Unicredit Bank
COIN
REXGBP
LSE
BW83
Toy.fa 26
LSE
CCGP
Claimar Care
BIT
ENCO
L&g Multi-strategy Enhan...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network